Article

How Low Might Medicare's Drug Payout Go?

By upholding the health-care overhaul, the Supreme Court keeps on track plans to eliminate a gap in Medicare’s Part D prescription-drug benefit, a popular provision among patients. Does the decision also set a course toward cutting what Medicare itself pays for drugs?

The so-called doughnut hole — designed to reduce the government’s spending on the benefit — has been tough on many seniors. This year, it requires them to pay the costs of their prescriptions when the tab comes in between $2,930 and $6,658. Above that, catastrophic insurance coverage kicks in, and patients typically pay just 5% of their drug costs.

Read the full story: http://tinyurl.com/cfem9rr

Source: The Wall Street Journal

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Interview with Miriam Freimer, MD, The Ohio State University Wexner Medical Center
Merrill H. Stewart, MD
Rachel Rohaidy, MD
Mansi Shah, MD
Mansi Shah, MD
CK Wang, MD, COTA
Gordon Crofoot, MD, PA
Merrill H. Stewart, MD
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Hamlet Gasoyan, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo